Lucid Genomics

Berlin, Germany

Lucid Genomics is an AI-powered platform that focuses on diagnostics and biomarker detection.

$1.4M raised

Sep 2024

Pre-Seed

Biotechnology Health Care Pharmaceutical Precision Medicine

Top Investors

another.vcCaesar VenturesMax Planck FoundationBIF PartnersMAX!mize

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Lucid Genomics

How much funding has Lucid Genomics raised?

Lucid Genomics has raised $1.4M in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2024.

Who are Lucid Genomics's investors?

Lucid Genomics's investors include another.vc, Caesar Ventures, Max Planck Foundation, BIF Partners, MAX!mize.

Where is Lucid Genomics headquartered?

Lucid Genomics is headquartered in Berlin, Germany.

What does Lucid Genomics do?

Lucid Genomics is an AI-powered platform that focuses on diagnostics and biomarker detection.

What stage is Lucid Genomics at?

Lucid Genomics is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 2, 2024.

MLA

"Lucid Genomics — Funding & Investors." VCBacked, September 2, 2024, https://www.vcbacked.co/company/lucid-genomics. Accessed June 3, 2026.

APA

VCBacked. (2024). Lucid Genomics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/lucid-genomics

Wikipedia (cite web)

{{cite web |title=Lucid Genomics — Funding & Investors |url=https://www.vcbacked.co/company/lucid-genomics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 2, 2024.

Similar Companies in Biotechnology